Brca1haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer

Autor: Li, Carman Man-Chung, Cordes, Alyssa, Oliphant, Michael U. J., Quinn, S. Aidan, Thomas, Mayura, Selfors, Laura M., Silvestri, Francesca, Girnius, Nomeda, Rinaldi, Gianmarco, Zoeller, Jason J., Shapiro, Hana, Tsiobikas, Christina, Gupta, Kushali P., Pathania, Shailja, Regev, Aviv, Kadoch, S. Cigall, Muthuswamy, Senthil K., Brugge, Joan S.

Publikováno v: Nature Genetics; 20240101, Issue: Preprints p1-13, 13p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Author Correction: Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer.

Autor: Li CM; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. carman_li@hms.harvard.edu., Cordes A; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Oliphant MUJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Quinn SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Thomas M; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Selfors LM; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Silvestri F; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Girnius N; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Rinaldi G; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Zoeller JJ; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Shapiro H; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Tsiobikas C; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Gupta KP; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Pathania S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biology, University of Massachusetts Boston, Boston, MA, USA., Regev A; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Genentech, South San Francisco, CA, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Muthuswamy SK; Cancer Research Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. joan_brugge@hms.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. joan_brugge@hms.harvard.edu.

Publikováno v: Nature genetics [Nat Genet] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.